COVID-19 International Drug Pregnancy Registry

Inclusion Criteria: * Pregnant or recently pregnant (up to 30 days after the end of pregnancy) at time of enrollment * Age ≥18 years at time of enrollment * With mild to severe COVID-19 during pregnancy * Either * Treated for COVID-19 with at least one of the medications included in Table 1 during pregnancy. For monoclonal antibodies, the exposure period also includes 90 days prior to the first day of the LMP or * Hospitalized and did not receive any pharmacological treatment specifically indicated for mild, moderate, or severe COVID-19 during pregnancy * Resident of a country where a Central Institutional Review Board (IRB) or Ethics Committee provided approval to conduct the study or clearance that approval is not required to conduct the study * Signed the informed consent form and submitted the baseline module "COVID-19 Medications During This Pregnancy" Exclusion Criteria: ● \<18 years of age